Warner Bros. Discovery has climbed 32% in a week and 7.4% in September. Yet the signals stacking up around it point in the opposite direction.
The picture hasn't materially changed since Monday's convergence report — but it has sharpened. The Argus Research Sell downgrade from Joseph Bonner remains the only outright bearish analyst call on the stock. It sits alongside a put/call ratio of 2.69, near the 52-week high of 2.86. Options traders were leaning defensive before the downgrade. They remain defensive after it.
The put/call ratio wasn't a one-day spike. It has climbed steadily — from around 1.85 in mid-August to 2.53 by late September to 2.69 today. That is a z-score of 1.84 above the 20-day mean of 2.46. For comparison, the 52-week low was 0.35. The options market has rotated from roughly balanced to heavily put-weighted across six weeks. That move happened while the stock was rallying.
The broader analyst community isn't chasing the move. Morgan Stanley raised its target to $31 on September 22 while holding at Equal-Weight. Barclays reinstated at Equal-Weight with a $29 target on September 17. The consensus is cautious and tight — targets cluster within a dollar or two of where WBD now trades at $30.90. Argus's Sell, with no price target disclosed, is the outlier. The bull-to-bear count stands at 2 buys and 1 sell.
Short interest has fallen 12.7% over the past week to 2.42% of free float — a low and unremarkable level. Covering into a rally is straightforward tape mechanics. It is not a bullish signal on its own.
The insider picture is more pointed. Net insider selling in the 90 days through September 14 totalled over $141 million across open-market disposals. None of the major trades by Director Anton Levy ($9.7M), Chief People Officer Amy Girdwood ($7.3M), or Director Kenneth Lowe ($11.3M combined) were under pre-arranged 10b5-1 plans. CEO David Zaslav's August sale was under a plan — worth noting — but it adds volume without offsetting the discretionary sales. Insiders have not bought into this rally.
What to watch: whether the Argus Sell attracts followers among the Equal-Weight cluster as the stock holds near analyst price targets — and whether insider selling resumes above $31.
See the live data behind this article on ORTEX.
Open WBD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
